Breast Cancer Session

Dr. Ahmad Matalkah, MD, FACS, is a Staff Physician & a Surgical Oncologist​ in the Digestive Disease Institute and Oncology Institute at Cleveland Clinic Abu Dhabi. Prior to Joining Cleveland Clinic Abu Dhabi, Dr. Matalkah worked as Surgical Oncologist within the Department of Surgery in King Hussein Cancer Center, Amman, Jordan. In this role, he provided patient care in the areas of advanced malignant upper gastrointestinal cancer, breast cancer, thyroid and parathyroid cancer, and pancreatic cancer. Dr. Matalkah received his medical degree from Jordan University of Science and Technology in Jordan. After completing his residency within the General Surgery Department of King Abdullah University Hospital, Amman, Jordan, he became a Surgical Oncology Fellow, within the General Surgery Department, King Hussein Cancer Center, Amman, Jordan. Dr. Matalkah was awarded the “Teacher of the Year” at Cleveland Clinic Abu Dhabi in 2018, in recognition and appreciation of his contributions to teaching of residents and interns. He is a member of many renowned medical associations including the American College of Surgeons and the European Society of Surgical Oncology.

Antonio Llombart Cussac, MD, PhD, is chairman of the Medical Oncology Service at the University Hospital Arnau de Vilanova in Valencia, Spain, and professor of Clinical Oncology at the Universidad Catolica de Valencia. Dr Llombart is actively involved in several Spanish and international cooperative groups for Breast Cancer. He is author of more than 200 indexed publications. Since 2012 is also a Senior Breast Cancer Advisor for MedSIR, a private research company focused on outstanding clinical trials in Cancer. Finally, he is coordinating a Research Cancer Unit exploring new agents both in human and animal models.

More than 20 years experience from UK & India Fully trained in the UK for 15 years. Ex-consultant Oncoplastic breast surgeon at Peterborough hospital (UK). Ex- Consultant Oncoplastic breast surgeon at Kokilaben Dhirubhai Ambani Hospital, Mumbai, India. Ex- Consultant Oncoplastic breast surgery at Narayana Health, Bangalore, India

Medical Oncologist and quality officer in Oncology at Tawam hospital, graduated from the MD Anderson Hematology and Medical Oncology fellowship in 2019. Main interest in breast cancer. Published several peer review research articles and multiple book chapters in breast cancer.

Dr. Bhawna Sirohi started her oncology career at Tata Memorial centre (TMC), Mumbai in 1994 and completed training at Royal Marsden NHS Foundation Trust, UK. She serves in Max Super specialty Hospital and is currently an honorary consultant with QMUL, London. At TMC in 2012-2014, she set up GI medical oncology &medical oncology information system (MOIS) for e-prescribing chemotherapy. She has been involved in initial setting up of cancer centres in Sangrur and Mohali, Punjab for TMC. She has piloted use of virtual consults using PROM & PREM in London.

Medical Oncology at Dubai Hospital

Dr. Diaeddine Trad is a Consultant of Medical Oncology, at Tawam Hospital, in Al Ain, UAE. He is a member of the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). He is an investigator in several ongoing clinical trials. Dr. Trad is certified as a specialist in internal medicine, hematology and oncology by the Lebanese Ministry of Health. His research interests include; non-small cell lung adenocarcinoma and locally advanced breast cancer. Dr. Trad was a speaker in many international conferences and forums.

Dr Fathi Azribi is a Consultant Medical Oncologist and Chief of Medical Oncology Division at Tawam Hospital. He graduated from Tripoli University, Libya, then completed specialty training in Oncology in the UK and obtained a Certificate of Completion of Training in Medical Oncology in October 2009. His main interest is in thoracic, breast, gynaecological and gastrointestinal malignancies; with expertise in treatment with chemotherapy, immunotherapy, hormonal and targeted therapy. He published several papers and abstracts in peer reviewed journals. He is also the Program Director of the medical oncology fellowship program at Tawam Hospital.

Giuseppe Curigliano, MD PhD, is Associate Professor of Medical Oncology at the University of Milano and the Head of the Division of Early Drug Development at the European Institute of Oncology, IRCCS, Italy. He is a clinician and researcher specialising in early drug development for patients with solid tumours with a special commitment to breast cancer. He has been a member of the Italian National Health Council since 2018 and, in 2019, he served as Chair of the Scientific Committee of The Lega Nazionale Lotta ai Tumori. 

Dr. Azim is a Professor of Clinical Oncology and immediate past chairman of the Department of Clinical Oncology, Faculty of Medicine, Cairo University. He is the president of the Cairo Oncology Center, one of the largest private Cancer centers in the Middle East region. Dr Azim chairs the scientific committee of the NCCN Middle East chapter and is a member of numerous societies, including the ASCO, ASH, ESMO, ASTRO and the European Blood and Marrow Transplantation Society.

Consultant Physician, Anatomic Pathology Division of Imaging and Laboratory, H.H. Sheikh Khalifa Specialty Hospital, Ras Al Khaimah, U.A.E. Clinical Assistant Professor Department of Pathology, Seoul National University Hospital, Seoul, Korea

Dr.Javier Cortes is a head of breast cancer and gynecological cancers at Hospital Universitario Ramón y Cajal in Madrid, Spain, as well as Clinical Investigator in the breast cancer research program at Vall d’Hebron Institute of Oncology in Barcelona, Spain.He is one of the European leaders in the field of HER2+ breast cancer, and has led fundamental trials that resulted in the approval of pertuzumab, eribulin and everolimus for metastatic breast cancer. He continues to actively participate in national and international clinical investigations to develop molecularly targeted therapies, such as CDK 4/6 inhibitors, and immunotherapies.Dr. Cortés is on the Scientific Committee of ESMO and is an active member of ASCO and the Spanish Society of Medical Oncology.

Mark Verrill is Head of the Department of Medical Oncology at the Northern Centre for Cancer Care at the Freeman Hospital, Newcastle upon Tyne and Lead Clinician for Breast Cancer in the Northern Cancer Alliance. He graduated from the University of Cambridge in 1999 before undertaking specialist training in Medical Oncology at the Royal Marsden Hospital and Institute of Cancer Research. Mark was appointed as Cancer Research Campaign Clinical Senior Lecturer in Medical Oncology in Newcastle University in 1999, moving into the NHS in 2007. Mark is an active in clinical research with an extensive breast cancer trial portfolio in NCCC and numerous publications resulting from clinical studies.

Dr. Bello is a highly experienced general and breast / Aesthetic Oncoplastic surgeon who has practiced for most of her career in the UK. She had worked at Nottingham Breast institute before moving to Noble’s Hospital on the Isle of Man, UK, where she was responsible for developing the landscape of breast care delivery on the island. She is a specialist in breast surgery and breast reconstruction, as well as a fully accredited general surgeon. Dr Millicent Alache Bello joins King’s with more than 35 years of experience both in the UK and UAE. Dr Bello completed her Bachelor of Medicine and Surgery (MBBS) in 1982 and earned FRCS (Ed) in 1991, FRCS (Gen.Surg Ed) in 2000, MPhil (Leicester) in 2005. She gained The Certificate of Completion of Specialist Training (CCST) in 2000.

.

Dr. Diab has been working with NMC since May 2014 as Consultant Medical Oncologist. He completed his MD in 2004 from Karolinska University, Sweden. Subsequently, he completed his Certificate in Bone Marrow Transplantation in 2008 from Oncology Hospital, Radiumhemmet. Dr. Diab was instrumental in setting up the Oncology clinic at NMC hospital, where he implemented updated chemotherapy protocols according to the highest international and European standards. He has also set up a one of its kind, unique tumour board, which meets weekly to discuss all cancer cases to ensure that each patient’s treatment is personalised and most appropriate to his/her needs. This tumour board is multi-disciplinary & consists of the onco-surgeon, onco-pathologist & onco-radiologist in addition to allied specialities. Prior to joining NMC, he was a Consultant Medical Oncologist since 2008 in the West Gotland Region in Sweden that had 2 hospitals having capacities of 525 and 300 beds respectively. He was also instrumental in setting up and leading the oncology clinics of these hospitals while in Sweden. Dr. Diab manages his own Medical Oncology study and participates actively in many studies for different Tumour diagnosis. He is multilingual and can communicate fluently in English, Arabic, Swedish and has knowledge of conversational Norwegian and Danish.

Dr.Mohsen Mokhtar is a professor of clinical oncology in Al-Kasr Al-Aini Medical School. Dr.Mokhtar has more than 20 years of experience in hospital management and he is currently the chief medical director in Elaj group covering the clinical and medical audit of group facilities. He is now focusing on clinical trials in breast, gynecological and prostate cancers.

Medical Oncologist at Tawam Hospital

Nagi S. El-Saghir, MD, FACP is Professor of Medicine and Director of Breast Center of Excellence, Naef K. Basile Cancer Institute, American University of Beirut Medical Center. Dr. Nagi El Saghir graduated from Universite Libre de Bruxelles, completed his training in New York, and is certified by the American Boards of Internal Medicine and Medical Oncology. Prof. El Saghir has over 100 publications in peer-reviewed journals and textbooks. His research is focused on breast cancer and young women, BRCA mutations, awareness and early detection, advanced breast cancer, multidisciplinary management, guidelines and international phase III clinical trials.

Dr. Nita S Nair is a surgical oncologist and a Professor in breast oncology at the Tata Memorial Centre in Mumbai , India. She is the current Convenor of the breast disease management group at TMC. After her training she joined Tata Memorial Hospital as a consultant in 2010 and has been involved in numerous clinical research trials , with a special focus on quality of life and young women cancers.She is an integral member of the research team, evaluating a wide array of clinical questions from low cost interventions like Low axillary sampling to Yoga on QOL for women with breast cancer. Dr. Nair is also faculty on the UEA oncoplastic surgery training course and has been involved in developing the oncoplastic breast surgery work at TMC and training numerous surgeons across India.

“Dr. Nitesh Rohatgi is a senior consultant in Medical Oncology at Max Hospital in Saket, who was till recently working at the prestigious London Oncology Clinic (Leaders in Oncology care), Harley Street, London. He is a fellow of the Royal Society of medicine and has much publication to his name. He was trained in medical oncology, palliative medicine and teenage young adult’s cancers in United Kingdom, completing his CCT in 2009.”

Dr.Nouri Bennini has served as Consultant Oncologist at the Tawam Hospital in Al Ain, United Arab Emirates, since 1999. He received his general medicine diploma in 1988 from the University of Constantine in Algeria and undertook residency in medical oncology at the University of Bordeaux, France. At the University of Montpellier, France, Dr. Bennini specialised in breast diseases. He has published several scientific papers and contributed to a number of oncology conferences.

“Dr. Peter Fasching is an Associate Professor of Gynecology and Obstetrics Translational Medicine, at the University Hospital Erlangen and Comprehensive Cancer Center Erlangen-EMN, Germany. He obtained his MD degree at the University of Cologne, Medical School and in 2006 he earned his Board Certification in Gynecology and Obstetrics at University Hospital Erlangen. He was a Research Fellow at the Department of Hematology/Oncology, UCLA, Los Angeles. Since 2011, he is the Head of the Clinical Trial Unit and Coordinator of the Breast Cancer Center and Gynecologic Oncology Center at the University Hospital Erlangen. He has served as Steering Committee member and Principal Investigator in several key breast cancer trials. Dr. Fasching’s research focus is on big data, statistical modelling, genomics and systems biology.”

Dr Rham is a Phd (Medical Oncology), MS (Internal Medicine), MBBch (Surgery, Medicine and ESMO (European Society Member of Oncology). She was a Lecturer of medical oncology at the Medical Oncology Department at Zagazig University Faculty of Medicine from 2011 to October 2014. Assistant lecturer at the National Cancer Institute, Cairo University and Faculty of Medicine at Zagazig University from 2004 – 2011. Dr Rham’s special intrest are in Early screening programs, Diagnosis and treatment of breast cancer,Diagnosis and treatment of GIT cancers, Diagnosis and treatment of uro genital cancers.

Dr. Shaheenah Dawood’s specialty is Oncology and currently works as a Consultant Oncologist in Mediclinic City Hospital. She currently serves as president of the Excellence in Oncology Care (EIOC) congress that is held annually in Dubai and is Co-Chair of the Asia Pacific Breast Cancer Summit (APBCS) & APGCS.

Dr. Shona Nag is currently Director of Oncology at Sahayadri Group of Hospitals in Pune. She is known for her work in women’s health – especially breast cancer, cervical cancer & developmental theraputics. With over 27 years of practice, Dr. Shona Nag, who studied medicine in Pune’s BJ Medical College, followed by an oncology fellowship at Tata Memorial Hospital in Mumbai has been Principal Investigator for over 40 Phase I, II, III global clinical Trials in Breast cancer, Ovarian cancer, lung cancer, Renal cell carcinoma, colorectal cancer.

Dr. Sonia Otsmane is an experienced Medical Oncology-Haematology Consultant since 2004. Graduated from the Central faculty of Medecine Algiers in 1994. MD degree. Oncology-hematology board : Pierre and Marie curie institute in 2004. ESMO member. Member of ASCO. Member of Emirates oncology and hematology society. Member of Oncology society and Algerian order of physicians. Main interest: breast cancer, sarcomas, GI and GU malignancies and lymphomas. Has an interest and implicated in several clinical research. Publications and research ongoing on Hematology malignancies (Multiple myeloma /Lymphoma), Solid tumors mainly Breast cancer Head and neck tumors and Immunotherapy. Currently working as Medical Oncology Hematology Physician at Sheikh Shakhbout Medical City.

Stephen Johnston is a Professor of Breast Cancer Medicine and Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London. He is currently a Clinical Director of the Breast, Lung and AOS Clinical Business Unit at The Royal Marsden. He has published over 250 breast cancer related articles in peer-reviewed journals, and is a regular invited lecturer at national and international meetings.

Dr. Sudeep Gupta is a Professor of Medical Oncology at Tata Memorial Hospital in Mumbai, India. Dr. Gupta obtained his MBBS degree from All India Institute of Medical Sciences (AIIMS) in New Delhi in 1992. He completed his Postgraduate (MD degree) in internal medicine in 1994 and his Medical Oncology training in 2000 at the same Institute. Following his Medical Oncology training, Dr. Gupta joined Tata Memorial hospital in Mumbai as an Assistant Professor in Medical Oncology and was promoted to Associate Professor in 2003 and Professor in 2010.

Dr. Syed is a medical oncologist with more than 15 years of experience. He completed Internal Medicine training from Columbia University in New York. He then completed an Oncology fellowship from New York Medical college. He is American Board certified in Medical Oncology and has successfully treated more than 5000 oncology patients.